The AT₁ angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol.
Paz
Maria Constanza
MC
Instituto de Farmacología Experimental Córdoba (IFEC-CONICET), Departamento de Farmacología, Facultad de Ciencias Químicas Universidad Nacional de Córdoba, Argentina.
Assis
Maria Amparo
MA
Cabrera
Ricardo J
RJ
Cancela
Liliana M
LM
Bregonzio
Claudia
C